Skip to content

Author

M. Romero-Gómez

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

New CLA3+/4 scores predict outcomes in MASLD.

BACKGROUND & AIMS Fibrosis is a major determinant of adverse outcomes in metabolic dysfunction-associated steatotic liver disease (MASLD). We developed and validated two probability scores for advanced fibrosis (≥F3) and cirrhosis (F4)-CLA3+ and CLA4-using controlled attenuation parameter (CAP), liver stiffness (LS) by...

Dong Hyun Kim, N. Cho, Terry Cheuk-Fung Yip et al. · 0 citations
Sep 2026

Personalised prediction of the individual risk of liver-related events in MASLD using the dynamics of non-invasive tests.

By automatically integrating and interpreting the dynamics of non-invasive tests of liver fibrosis, JLCM enables the personalised prediction of the risk of hard outcomes, rather than the imperfect evaluation of histological surrogates.

C. Moreau, M. Roux, J. Riou et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.